• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的线粒体复合体I缺乏症。

Mitochondrial complex I deficiency in Parkinson's disease.

作者信息

Schapira A H, Cooper J M, Dexter D, Clark J B, Jenner P, Marsden C D

机构信息

Department of Neurological Science, Royal Free Hospital School of Medicine, London, England.

出版信息

J Neurochem. 1990 Mar;54(3):823-7. doi: 10.1111/j.1471-4159.1990.tb02325.x.

DOI:10.1111/j.1471-4159.1990.tb02325.x
PMID:2154550
Abstract

The structure and function of mitochondrial respiratory-chain enzyme proteins were studied postmortem in the substantia nigra of nine patients with Parkinson's disease and nine matched controls. Total protein and mitochondrial mass were similar in the two groups. NADH-ubiquinone reductase (Complex I) and NADH cytochrome c reductase activities were significantly reduced, whereas succinate cytochrome c reductase activity was normal. These results indicated a specific defect of Complex I activity in the substantia nigra of patients with Parkinson's disease. This biochemical defect is the same as that produced in animal models of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and adds further support to the proposition that Parkinson's disease may be due to an environmental toxin with action(s) similar to those of MPTP.

摘要

对9例帕金森病患者和9例匹配的对照者的黑质进行尸检,研究线粒体呼吸链酶蛋白的结构和功能。两组的总蛋白和线粒体质量相似。NADH-泛醌还原酶(复合体I)和NADH细胞色素c还原酶活性显著降低,而琥珀酸细胞色素c还原酶活性正常。这些结果表明帕金森病患者黑质中复合体I活性存在特异性缺陷。这种生化缺陷与1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)在帕金森病动物模型中产生的缺陷相同,进一步支持了帕金森病可能是由一种作用类似于MPTP的环境毒素引起的这一观点。

相似文献

1
Mitochondrial complex I deficiency in Parkinson's disease.帕金森病中的线粒体复合体I缺乏症。
J Neurochem. 1990 Mar;54(3):823-7. doi: 10.1111/j.1471-4159.1990.tb02325.x.
2
Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease.帕金森病患者骨骼肌中的呼吸链异常。
J Neurol Sci. 1991 Aug;104(2):203-8. doi: 10.1016/0022-510x(91)90311-t.
3
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
J Neurochem. 1990 Dec;55(6):2142-5. doi: 10.1111/j.1471-4159.1990.tb05809.x.
4
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.泛醌(辅酶Q10)与帕金森病氧化应激中的线粒体
Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889.
5
Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease.早期未经治疗的帕金森病患者血小板线粒体复合物I及复合物II/III活性降低
Ann Neurol. 1995 Jun;37(6):714-22. doi: 10.1002/ana.410370604.
6
Direct interaction between mitochondrial succinate-ubiquinone and ubiquinol-cytochrome c oxidoreductases probed by sensitivity to quinone-related inhibitors.通过对醌类相关抑制剂的敏感性探究线粒体琥珀酸-泛醌和泛醇-细胞色素c氧化还原酶之间的直接相互作用。
J Biochem. 1996 Aug;120(2):377-84. doi: 10.1093/oxfordjournals.jbchem.a021423.
7
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.辅酶Q10水平与帕金森病患者和非帕金森病患者线粒体中复合物I及复合物II/III的活性相关。
Ann Neurol. 1997 Aug;42(2):261-4. doi: 10.1002/ana.410420221.
8
Direct interaction between yeast NADH-ubiquinone oxidoreductase, succinate-ubiquinone oxidoreductase, and ubiquinol-cytochrome c oxidoreductase in the reduction of exogenous quinones.酵母NADH-泛醌氧化还原酶、琥珀酸-泛醌氧化还原酶和泛醇-细胞色素c氧化还原酶在还原外源醌过程中的直接相互作用。
J Biol Chem. 1988 Jan 5;263(1):193-9.
9
[Abnormality in the mitochondrial energy-producing system].[线粒体能量产生系统异常]
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):824-7.
10
Abnormalities of the electron transport chain in idiopathic Parkinson's disease.特发性帕金森病中电子传递链的异常
Ann Neurol. 1989 Dec;26(6):719-23. doi: 10.1002/ana.410260606.

引用本文的文献

1
Animal Models for the Study of Neurological Diseases and Their Link to Sleep.用于研究神经疾病及其与睡眠关系的动物模型
Biomedicines. 2025 Aug 18;13(8):2005. doi: 10.3390/biomedicines13082005.
2
Epigenetic regulation of the respiratory chain by a mitochondrial distress-related redox signal.线粒体应激相关氧化还原信号对呼吸链的表观遗传调控。
Front Cell Dev Biol. 2025 Aug 5;13:1608400. doi: 10.3389/fcell.2025.1608400. eCollection 2025.
3
Iron mishandling in the brain and periphery in Parkinson's disease.帕金森病中大脑和外周铁处理不当
NPJ Parkinsons Dis. 2025 Aug 18;11(1):246. doi: 10.1038/s41531-025-01089-7.
4
Potentiation of mitochondrial function by mitoDREADD-G reverses pharmacological and neurodegenerative cognitive impairment in mice.线粒体设计受体激动剂-G增强线粒体功能可逆转小鼠的药物性和神经退行性认知障碍。
Nat Neurosci. 2025 Aug 11. doi: 10.1038/s41593-025-02032-y.
5
Integrated Behavioral and Proteomic Characterization of MPP-Induced Early Neurodegeneration and Parkinsonism in Zebrafish Larvae.MPP诱导斑马鱼幼虫早期神经退行性变和帕金森病的行为与蛋白质组学综合表征
Int J Mol Sci. 2025 Jul 15;26(14):6762. doi: 10.3390/ijms26146762.
6
Organic cation transporter 3 on neuronal mitochondria mediates MPP-induced mitochondrial dysfunction and neurotoxicity in a TIMM22-dependent manner.神经元线粒体上的有机阳离子转运体3以TIMM22依赖的方式介导MPP诱导的线粒体功能障碍和神经毒性。
BMC Biol. 2025 Jul 15;23(1):214. doi: 10.1186/s12915-025-02318-4.
7
Deficient AMPK-SENP1-Sirt3 signaling impairs mitochondrial complex I function in Parkinson's disease model.在帕金森病模型中,AMPK-SENP1-Sirt3信号通路缺陷会损害线粒体复合体I的功能。
Transl Neurodegener. 2025 Jul 1;14(1):34. doi: 10.1186/s40035-025-00489-2.
8
Role of Cellular Senescence in Parkinson's Disease: Potential for Disease-Modification Through Senotherapy.细胞衰老在帕金森病中的作用:通过衰老疗法进行疾病修饰的潜力。
Biomedicines. 2025 Jun 7;13(6):1400. doi: 10.3390/biomedicines13061400.
9
Constraint-based modeling of bioenergetic differences between synaptic and non-synaptic components of dopaminergic neurons in Parkinson's disease.帕金森病中多巴胺能神经元突触和非突触成分生物能量差异的基于约束的建模
Front Comput Neurosci. 2025 Jun 5;19:1594330. doi: 10.3389/fncom.2025.1594330. eCollection 2025.
10
Current trends and future prospects of N-acetylcysteine utilizations in Parkinson's disease: A literature network analysis.N-乙酰半胱氨酸在帕金森病中的应用现状与未来展望:一项文献网络分析
J Taibah Univ Med Sci. 2025 May 29;20(3):298-306. doi: 10.1016/j.jtumed.2025.05.004. eCollection 2025 Jun.